Ravi Kiron
Consultant / Advisor at ShangPharma Innovation, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert Bourla | M | 62 | 31 years | |
| Joel Bennett Braunstein | M | - |
C2N Diagnostics LLC
 C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | 17 years |
| Douglas Lankler | M | 58 | 25 years | |
| Mohamad Tabrizi | M | - |
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | 7 years |
| Robert A. Drakas | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | 8 years |
| Lisa Walsh | F | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 41 years |
| William Hait | M | 74 | 17 years | |
| Rady Johnson | M | 63 | 30 years | |
| Ya Jun Xu | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Stephen Munk | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Fernando Dangond | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Charles Yang | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| David Sahner | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Eric Parker | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Juan-Carlos Lopez | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Grant Green | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | 6 years |
| Jean Bidegainberry | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Sarah Lively | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Cheryl Schwartz | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Mike McDermott | M | 58 | 21 years | |
| Chris Round | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Payal Sahni Becher | F | - | 27 years | |
| Robert Lutz | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| John DeYoung | M | 61 | 33 years | |
| Xin Hui | M | 53 |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Jennifer Taubert | F | 60 | 19 years | |
| Ruediger Weseloh | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Gary DiCamillo | M | 73 |
Rensselaer Polytechnic Institute
| 28 years |
| Michael MacDougall | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 17 years |
| Suneet Varma | M | 55 | 23 years | |
| Robert Wild | M | 53 |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | 7 years |
| Krishna Kodukula | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Tim Golden | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 30 years |
| David Spellmeyer | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | 7 years |
| Peter DiLaura | M | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Dirk Brockstedt | M | 55 |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | - |
| Elizabeth Forminard | F | 53 | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry McKinnell | M | 81 | 8 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| James T. Lenehan | M | 75 | 28 years | |
| George A. Lorch | M | 82 | 15 years | |
| Constance J. Horner | F | 82 | - | |
| Shashank N. Desai | M | - |
University of Mumbai
| 7 years |
| Kirit Vishanji Gala | M | 61 |
University of Mumbai
| 6 years |
| Michael R. Jirousek | M | 65 | 5 years | |
| Dan G. Keller | M | 65 | - | |
| Girish Nadkarni | M | - |
University of Mumbai
| 7 years |
| Joseph M. Danis | M | - | 10 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Carla Sivak | F | - | 4 years | |
| Susan L. Lindquist | M | 74 | - | |
| Alka Marezban Bharucha | F | 67 |
University of Mumbai
| 7 years |
| Joseph Truitt | M | 59 | 4 years | |
| Jonathan Emms | M | - | 20 years | |
| Purushottam Sitaram Mantri | M | 66 |
University of Mumbai
| 8 years |
| Christopher DelOrefice | M | 52 | 8 years | |
| Lisa Romanko | F | - | 19 years | |
| Jennifer Schroeder | F | - | 20 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| George Oetomo | M | 51 |
Rensselaer Polytechnic Institute
| 6 years |
| Paul Fitzhenry | M | 63 | 4 years | |
| Evan Norton | M | 49 | 3 years | |
| Martin MacKay | M | 68 | 14 years | |
| Dana George Mead | M | 88 | 12 years | |
| Gary Zieziula | M | 69 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Marc Robinson | M | 63 | 11 years | |
| Sanjiv Suri | M | 65 |
University of Mumbai
| 3 years |
| Wyllie Cornwell | M | 76 | 23 years | |
| Robert N. Burt | M | 86 | 11 years | |
| Franklin Raines | M | 74 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| Michael Brown | M | 82 | 16 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Peter Corr | M | 76 | 6 years | |
| Natasha Kehimkar | F | - | 16 years | |
| George Milne | M | 80 | 32 years | |
| Charles O. Prince | M | 74 | 17 years | |
| Sanjay Sachdev | M | 62 |
University of Mumbai
| 7 years |
| Stephanie O'Brien | F | 65 | 9 years | |
| Anand R. Baichwal | M | 69 |
University of Mumbai
| 6 years |
| Michael Johns | M | 82 | 9 years | |
| Ronit Bendori | M | - | 6 years | |
| Kim Rodriguez | F | - | 2 years | |
| Anil D. Harish | M | 70 |
University of Mumbai
| 3 years |
| Lisa Shapiro Strovink | F | - | 1 years | |
| Yeng Cheong Thaw | M | 65 |
University of Mumbai
| 4 years |
| Michael Warner | M | - | 16 years | |
| Charles Baum | M | 65 | 9 years | |
| Elizabeth Hanna | F | 59 | 8 years | |
| Catherine Knupp | M | 63 | - | |
| Michael Dunne | M | 64 | 17 years | |
| Nenad Sarapa | M | - | 6 years | |
| Tariq Arshad | M | 54 | 12 years | |
| Rajiv Sarman Shukla | M | 49 | 5 years | |
| Mark White | M | 68 | 12 years | |
| Roger Leone | M | - | 14 years | |
| Mark J. Bamberger | M | 71 | 4 years | |
| Ken Berlin | M | 59 | 13 years | |
| Ravindra Anant Khot | M | - |
University of Mumbai
| 4 years |
| Girish M. Khandekar | M | - |
University of Mumbai
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
| India | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ravi Kiron
- Personal Network
